In the patients with intrahepatic cholangiocarcinoma, harboring IDH mutations, it took longer time for tumor recurrence after surgical resection and helped for longer overall survival compared to those without IDH mutations [79]. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.